| UNII | Excipient | CAS No. | Route | Dosage Form | Potency Amount | Historical Data |
|---|---|---|---|---|---|---|
| 21334LVV8W | .ALPHA.-TERPINEOL | 98-55-5 | TOPICAL | LOTION | 11%V/V | view |
| 21334LVV8W | .ALPHA.-TERPINEOL | 98-55-5 | TOPICAL | SOLUTION | 11%V/V | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | BUCCAL | FILM, SOLUBLE | 0.07MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION | 0.064% | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | CAPSULE | 1MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | CAPSULE | 0.5MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | CAPSULE, SOFT GELATIN | 1MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | CAPSULE, SOFT GELATIN | 5MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | SOLUTION | 1.05MG/1ML | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | TABLET | 42.5MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | TABLET | 0.3MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 0.1MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | TABLET, EXTENDED RELEASE | 0.2MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL | TABLET, SUSTAINED ACTION | 1.34MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL-21 | TABLET | 0.1MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | ORAL-28 | TABLET | 0.1MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | TOPICAL | OINTMENT | 0.001%W/W | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | TOPICAL | OINTMENT | 0.002%W/W | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | TOPICAL | PATCH | 0.099MG | view |
| H4N855PNZ1 | .ALPHA.-TOCOPHEROL | 1406-18-4 | TRANSDERMAL | PATCH | 0.09MG | view |